PML-IRIS during Fingolimod Diagnosed after Natalizumab Discontinuation
Background. Natalizumab treatment is frequently discontinued and replaced by alternative medication in multiple sclerosis (MS) patients having a high risk of progressive multifocal leukoencephalopathy (PML). Case Presentation. We report a PML case that was missed on magnetic resonance imaging (MRI)...
Saved in:
Main Authors: | J. Killestein, A. Vennegoor, A. E. L. van Golde, R. L. J. H. Bourez, M. L. B. Wijlens, M. P. Wattjes |
---|---|
Format: | Article |
Language: | English |
Published: |
Wiley
2014-01-01
|
Series: | Case Reports in Neurological Medicine |
Online Access: | http://dx.doi.org/10.1155/2014/307872 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Progressive Multifocal Leukoencephalopathy in a Multiple Sclerosis Patient Diagnosed after Switching from Natalizumab to Fingolimod
by: Tim Sinnecker, et al.
Published: (2016-01-01) -
Intermittent Atrioventricular Block following Fingolimod Initiation
by: E. Gialafos, et al.
Published: (2014-01-01) -
PML-RARA Fusion Transcripts Detectable 8 Months prior to Promyelocytic Blast Crisis in Chronic Myeloid Leukemia
by: Stephanie Wolanin, et al.
Published: (2020-01-01) -
High-Risk Microgranular Acute Promyelocytic Leukemia with a Five-Way Complex Translocation Involving PML-RARA
by: Benjamin Powers, et al.
Published: (2015-01-01) -
Iris tectorum Japanese Roof Iris, Wall Iris
by: Edward Gilman, et al.
Published: (2007-05-01)